Iovance Biotherapeutics Inc. buy Wells Fargo & Company
Start price
30.05.23
/
50%
€7.97
Target price
30.05.24
€15.85
Performance (%)
4.72%
End price
31.05.24
€8.35
Summary
This prediction ended on 31.05.24 with a price of €8.35. With a performance of 4.72%, the BUY prediction by Wells_Fargo___Compan for Iovance Biotherapeutics Inc. closed with a slight gain. Wells_Fargo___Compan has a follow-up prediction for Iovance Biotherapeutics Inc. where he still thinks Iovance Biotherapeutics Inc. is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Iovance Biotherapeutics Inc. | 13.893% | 13.893% | 35.358% |
| iShares Core DAX® | 0.039% | 0.567% | 12.281% |
| iShares Nasdaq 100 | -4.018% | -5.554% | 23.851% |
| iShares Nikkei 225® | -2.389% | -1.434% | 8.335% |
| iShares S&P 500 | -2.115% | -2.351% | 22.061% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $17.00 price target on the stock, up previously from $11.00.
Ratings data for IOVA provided by MarketBeat
In the thread Trading Iovance Biotherapeutics Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€11.70
20.02.24
20.02.24
€20.35
20.02.25
20.02.25
-25.73%
25.07.24
25.07.24
